Lexeo Therapeutics (LXEO) Stock Chart & Stock Price History $4.43 +0.05 (+1.14%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lexeo Therapeutics Stock Price Performance The Lexeo Therapeutics (LXEO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 71.40%, with a year-to-date return of -32.67%. In the past month, the stock has increased 35.47%, reflecting recent market activity. As of the latest close, Lexeo Therapeutics traded at $4.43 with a market cap of $147.08 million and volume of 193,219 shares. Receive LXEO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lexeo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+10.20%1 Month Performance+35.47%3 Month Performance+89.32%Year-To-Date Performance-32.67%1 Year Performance-71.40% LXEO Stock Chart for Saturday, July, 5, 2025 LXEO Chart by TradingView Lexeo Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$4.43$4.43$4.50$4.32193,219 shs$147.08 million07/03/2025$4.38$4.43+1.14%$4.50$4.32193,219 shs$147.08 million07/02/2025$4.22$4.38+3.79%$4.49$4.16264,315 shs$145.42 million07/01/2025$4.02$4.22+4.98%$4.47$3.91663,299 shs$140.09 million06/30/2025$4.12$4.02-2.43%$4.18$3.96281,769 shs$133.46 million06/27/2025$4.18$4.12-1.44%$4.20$4.01959,826 shs$136.78 million06/26/2025$4.19$4.18-0.24%$4.22$4.00442,159 shs$138.78 million06/25/2025$4.21$4.19-0.48%$4.50$4.06732,581 shs$139.11 million06/24/2025$3.96$4.21+6.31%$4.26$3.98514,448 shs$139.77 million06/23/2025$3.91$3.96+1.28%$4.00$3.74494,627 shs$131.46 million Get the Latest News and Ratings for LXEO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexeo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$4.24$3.91-7.78%$4.27$3.63756,031 shs$129.81 million06/19/2025$4.24$4.24$4.24$3.75429,734 shs$140.77 million06/18/2025$3.92$4.24+8.16%$4.24$3.75429,734 shs$140.76 million06/17/2025$3.92$3.92$3.98$3.62687,816 shs$130.13 million06/16/2025$3.94$3.92-0.51%$4.29$3.83553,880 shs$130.13 million06/13/2025$4.09$3.94-3.67%$4.20$3.85354,940 shs$130.80 million06/12/2025$4.51$4.09-9.31%$4.45$4.04531,587 shs$135.78 million06/11/2025$4.61$4.51-2.17%$4.75$4.26824,809 shs$149.72 million06/10/2025$4.38$4.61+5.25%$4.63$4.27826,200 shs$153.04 million06/09/2025$3.88$4.38+12.89%$4.40$3.85870,717 shs$145.40 million06/06/2025$3.27$3.88+18.65%$4.21$3.301.93 million shs$128.80 million06/05/2025$3.10$3.27+5.48%$3.33$2.90705,236 shs$108.55 million06/04/2025$2.82$3.10+9.93%$3.18$2.80647,666 shs$102.91 million Related Companies Tango Therapeutics Stock Chart Maze Therapeutics Stock Chart MeiraGTx Stock Chart Opthea Stock Chart Taysha Gene Therapies Stock Chart Bicycle Therapeutics Stock Chart Mind Medicine (MindMed) Stock Chart Valneva Stock Chart Zevra Therapeutics Stock Chart Kura Oncology Stock Chart Receive LXEO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lexeo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LXEO) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexeo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexeo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
